Justin P. Ingram

1.7k total citations · 1 hit paper
16 papers, 916 citations indexed

About

Justin P. Ingram is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Justin P. Ingram has authored 16 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Justin P. Ingram's work include interferon and immune responses (6 papers), Influenza Virus Research Studies (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Justin P. Ingram is often cited by papers focused on interferon and immune responses (6 papers), Influenza Virus Research Studies (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Justin P. Ingram collaborates with scholars based in United States, Japan and Canada. Justin P. Ingram's co-authors include Siddharth Balachandran, Katherine B. Ragan, Jason W. Upton, David F. Boyd, Paul G. Thomas, Maria Shubina, Roshan J. Thapa, Ting Zhang, Chaoran Yin and Diego A. Rodríguez and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Justin P. Ingram

14 papers receiving 896 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis

2020 370 citations Ting Zhang, Chaoran Yin et al. Cell profile →

Peers

Countries citing papers authored by Justin P. Ingram

Since Specialization

Citations

This map shows the geographic impact of Justin P. Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin P. Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin P. Ingram more than expected).

Fields of papers citing papers by Justin P. Ingram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin P. Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin P. Ingram. The network helps show where Justin P. Ingram may publish in the future.

Co-authorship network of co-authors of Justin P. Ingram

This figure shows the co-authorship network connecting the top 25 collaborators of Justin P. Ingram. A scholar is included among the top collaborators of Justin P. Ingram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin P. Ingram. Justin P. Ingram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Lipid Composition Alters Ferroptosis Sensitivity 2025 ·Cancer Research ·(unknown), (unknown), Justin P. Ingram, (unknown), Julie J. Purkal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sarah Kongpachith, Darren C. Phillips, Scott J. Dixon, Relja Popovic	0
2	Data from Lipid Composition Alters Ferroptosis Sensitivity 2025 ·(unknown), (unknown), Justin P. Ingram, (unknown), Julie J. Purkal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sarah Kongpachith, Darren C. Phillips, Scott J. Dixon, Relja Popovic	0
3	Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2 2024 ·Blood ·Darren C. Phillips, (unknown), Cory Alvey, Justin P. Ingram, Lloyd T. Lam, Ziping Yang, Jacob Riehm, Jun Chen, (unknown), Peter Kovar, Jin Wang, George Doherty, Vikram Bhat, Yujia Dai, Andrew S. Judd, Andrew J. Souers	1
4	NON-MUSCLE INVASIVE RECURRENCE AND MANAGEMENT DURING SURVEILLANCE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ACHIEVE CLINICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY 2024 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), Rainjade Chung, Justin P. Ingram, (unknown), G. Joel DeCastro, Christopher B. Anderson, James M. McKiernan, Andrew T. Lenis	1
5	Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy 2023 ·Urologic Oncology Seminars and Original Investigations ·Rainjade Chung, George W. Moran, (unknown), Daniel Pohl, Justin P. Ingram, Andrew T. Lenis, James M. McKiernan, Christopher B. Anderson, Izak Faiena	4
6	Perceived Barriers Among Underrepresented and Historically Marginalized Medical Students Pursuing a Career in Urology 2023 ·Urology ·(unknown), Justin P. Ingram, (unknown), Gregory Joice, Gina M. Badalato	1
7	Phase 2 trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder. 2023 ·Journal of Clinical Oncology ·G. Joel DeCastro, Christopher B. Anderson, Cory Abate‐Shen, (unknown), Justin P. Ingram, Mark N. Stein, James M. McKiernan	3
8	Structure-Based Design of A-1293102, a Potent and Selective BCL-X_L Inhibitor 2021 ·ACS Medicinal Chemistry Letters ·Zhi‐Fu Tao, Xilu Wang, Jun Chen, Justin P. Ingram, Sha Jin, Russell A. Judge, Peter Kovar, Chang Park, Chaohong Sun, (unknown), Li Zhou, Haichao Zhang, Steven W. Elmore, Darren C. Phillips, Andrew S. Judd, Joel Johansson, Andrew J. Souers	14
9	Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis breakdown → 2020 ·Cell ·Ting Zhang, Chaoran Yin, David F. Boyd, Giovanni Quarato, Justin P. Ingram, Maria Shubina, Katherine B. Ragan, Takumi Ishizuka, Jeremy Chase Crawford, Bart Tummers, Diego A. Rodríguez, Jia Xue, Suraj Peri, William J. Kaiser, Carolina B. López, Yan Xu, Jason W. Upton, Paul G. Thomas, Douglas R. Green, Siddharth Balachandran	370
10	ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1 2019 ·The Journal of Immunology ·Justin P. Ingram, Roshan J. Thapa, Amanda Fisher, Bart Tummers, Ting Zhang, Chaoran Yin, Diego A. Rodríguez, Hongyan Guo, Rebecca Lane, Riley Williams, Michael Slifker, Suresh H. Basagoudanavar, Glenn F. Rall, Christopher P. Dillon, Douglas R. Green, William J. Kaiser, Siddharth Balachandran	81
11	A Nonpyroptotic IFN-γ–Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance In Vivo 2018 ·The Journal of Immunology ·Justin P. Ingram, Sarah A. Tursi, Ting Zhang, Wei Guo, Chaoran Yin, Meghan A. Wynosky-Dolfi, Joris van der Heijden, Kathy Q. Cai, Masahiro Yamamoto, B. Brett Finlay, Igor E. Brodsky, Sergei I. Grivennikov, Çağla Tükel, Siddharth Balachandran	13
12	Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death 2017 ·Nature Communications ·Boris Hartmann, Randy A. Albrecht, Elena Zaslavsky, German Nudelman, Hanna Pinças, Nada Marjanović, Michael Schotsaert, Carles Martínez‐Romero, Rafael Fenutría, Justin P. Ingram, Irene Ramos, Ana Fernández-Sesma, Siddharth Balachandran, Adolfo Garcı́a-Sastre, Stuart C. Sealfon	41
13	DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death 2016 ·Cell Host & Microbe ·Roshan J. Thapa, Justin P. Ingram, Katherine B. Ragan, Shoko Nogusa, David F. Boyd, Asiel A. Benitez, Haripriya Sridharan, Rachelle Kosoff, Maria Shubina, (unknown), Mark Andrake, Peter Vogel, Luis J. Sigal, Benjamin R. tenOever, Paul G. Thomas, Jason W. Upton, Siddharth Balachandran	323
14	Interferon-γ in Salmonella pathogenesis: New tricks for an old dog 2016 ·Cytokine ·Justin P. Ingram, Igor E. Brodsky, Siddharth Balachandran	25
15	RIPK3 Is Largely Dispensable for RIG-I-Like Receptor- and Type I Interferon-Driven Transcriptional Responses to Influenza A Virus in Murine Fibroblasts 2016 ·PLoS ONE ·Shoko Nogusa, Michael Slifker, Justin P. Ingram, Roshan J. Thapa, Siddharth Balachandran	7
16	ERCP in the management of pediatric pancreatitis 1998 ·Gastrointestinal Endoscopy ·(unknown), Justin P. Ingram, Stephen E. Steinberg, Michael R. Narkewicz	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact